M. Romano

Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis.

R. Marmo, I. de Sio, N. Caporaso, 1991, Journal of hepatology.

Prevalence of hepatitis C virus infection in the household contacts of patients with HCV-related chronic liver disease

N. Caporaso, F. Morisco, M. D'antonio, 1994, Infection.

A COMPARISON OF FOUR TYPES OF INTERFERON ALPHA IN THE TREATMENT OF CHRONIC HEPATITIS C

M. Malaguarnera, L. Ferlito, I. Fazio, 1998 .

[HCV superinfection in a chronic carrier of HBV].

M. Pesce, M. Di Napoli, M. Romano, 1995, Minerva gastroenterologica e dietologica.

Hepatitis C virus RNA in serum and liver histology in asymptomatic anti-HCV positive subjects

N. Caporaso, F. Morisco, M. Persico, 1995, Infection.

Familial clustering of hepatitis C virus infection and chronic liver disease.

N. Caporaso, F. Morisco, M. Coltorti, 1990, The Italian journal of gastroenterology.

Recombinant human interferon alpha-2a therapy for chronic hepatitis C with or without cirrhosis: comparison of 3 or 6 MU for 1 year.

N. Caporaso, F. Morisco, M. D'antonio, 1993, The Italian journal of gastroenterology.

Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia.

M. Soresi, A. Florena, G. Montalto, 2009, Clinical radiology.